An observational study in Covid19, sponsored by Universität des Saarlandes. Recruiting at 1 site in Germany. Open to participants aged 0 Years to 110 Years. Per ClinicalTrials.gov, last updated 2025-05-25.
Sponsored by Universität des Saarlandes · Observational
The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19
Patients with all forms of COVID-19 are included and followed up. Medical history, measurements and biomarkers are registered and collected at baseline, dung hospitalization and after discharge. In addition, patients with LONG-COVID-19 are recruited.
Universität des Saarlandes is the lead sponsor of 64 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All COVID-19 patients in the State of Saarland
all form of COVID-19 including long-COVID-19
Exclusion Criteria:
-
The serum concentrations of multiple cytokines are measured.
Correlation of biomarkers with mortality and disease subgroups
Time frame: 2 years after initial disease
Plan to share: Yes
Supporting information: Study protocol
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universität des Saarlandes